000 01577 a2200397 4500
005 20250514034911.0
264 0 _c20020718
008 200207s 0 0 eng d
022 _a1097-6744
024 7 _a10.1067/mhj.2002.123111
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEisenstein, Eric L
245 0 0 _aVasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure.
_h[electronic resource]
260 _bAmerican heart journal
_cJun 2002
300 _a1112-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aCardiotonic Agents
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHospital Costs
650 0 4 _aHospitalization
_xeconomics
650 0 4 _aHumans
650 0 4 _aLisinopril
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProtease Inhibitors
_xtherapeutic use
650 0 4 _aPyridines
_xtherapeutic use
650 0 4 _aThiazepines
_xtherapeutic use
700 1 _aNelson, Charlotte L
700 1 _aSimon, Teresa A
700 1 _aSmitten, Allison L
700 1 _aLapuerta, Pablo
700 1 _aMark, Daniel B
773 0 _tAmerican heart journal
_gvol. 143
_gno. 6
_gp. 1112-7
856 4 0 _uhttps://doi.org/10.1067/mhj.2002.123111
_zAvailable from publisher's website
999 _c11970194
_d11970194